Skip to main content

and
  1. Article

    Open Access

    A deep learning methodology for improved breast cancer diagnosis using multiparametric MRI

    Multiparametric magnetic resonance imaging (mpMRI) has been shown to improve radiologists’ performance in the clinical diagnosis of breast cancer. This machine learning study develops a deep transfer learning ...

    Qiyuan Hu, Heather M. Whitney, Maryellen L. Giger in Scientific Reports (2020)

  2. No Access

    Chapter and Conference Paper

    Feedforward Deep Neural Network-Based Model for the Forecast of Severe Convective Wind

    In this study, we compared and analyzed the environmental characteristics in Shaanxi between 2016–2018 (before and after the occurrence of convective wind) based on both severe and non-severe wind samples extr...

    Yu **g, Nan Wang, Qiang Zhao, **yun Li in Advances in Artificial Intelligence and Se… (2021)

  3. No Access

    Chapter and Conference Paper

    MUGEN: A Playground for Video-Audio-Text Multimodal Understanding and GENeration

    Multimodal video-audio-text understanding and generation can benefit from datasets that are narrow but rich. The narrowness allows bite-sized challenges that the research community can make progress on. The ri...

    Thomas Hayes, Songyang Zhang, ** Yin, Guan Pang, Sasha Sheng in Computer Vision – ECCV 2022 (2022)

  4. Article

    Open Access

    Advanced polymer hydrogels that promote diabetic ulcer healing: mechanisms, classifications, and medical applications

    Diabetic ulcers (DUs) are one of the most serious complications of diabetes mellitus. The application of a functional dressing is a crucial step in DU treatment and is associated with the patient's recovery an...

    Yamei Xu, Qiyuan Hu, Zongyun Wei, Yi Ou, Youde Cao, Hang Zhou in Biomaterials Research (2023)

  5. Article

    Open Access

    Development and validation of a deep learning-based microsatellite instability predictor from prostate cancer whole-slide images

    Microsatellite instability-high (MSI-H) is a tumor-agnostic biomarker for immune checkpoint inhibitor therapy. However, MSI status is not routinely tested in prostate cancer, in part due to low prevalence and ...

    Qiyuan Hu, Abbas A. Rizvi, Geoffery Schau, Kshitij Ingale in npj Precision Oncology (2024)